Evaluation of the prophylaxis and treatment of COVID-associated coagulopathy
Most of the current “literature” surrounding the presence of thrombosis in COVID-19 disease and appropriate prophylaxis/treatment modalities is certainly retrospective at best, and anecdotal at worst. But in these times of rapidly changing information and perspective, an assessment of all available...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2020-12-01
|
| Series: | Journal of Pharmaceutical Policy and Practice |
| Online Access: | http://dx.doi.org/10.1186/s40545-020-00274-8 |